Kindstar Globalgene Technology, Inc. (9960) Stock Statistics & Valuation Metrics

Kindstar Globalgene Technology, Inc. has a market cap or net worth of HK$1.43B. The enterprise value is HK$1.22B.

Kindstar Globalgene Technology, Inc. has 1,040,758,400 shares outstanding. The number of shares has decreased by -2.65% in one year.

Kindstar Globalgene Technology, Inc.’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is -1.63%.

The current PE Ratio of Kindstar Globalgene Technology, Inc. is -19.21. Kindstar Globalgene Technology, Inc.’s PEG ratio is 0.17.

In the last 12 months, Kindstar Globalgene Technology, Inc. had revenue of 927.57M and earned -54.59M in profits. Earnings per share was -0.06.

In the last 12 months, operating cash flow was -70.25M and capital expenditures -95.22M, giving a free cash flow of -165.47M billion.

Kindstar Globalgene Technology, Inc. pays an annual dividend of HK$0.024, resulting in a dividend yield of 1.76%

Kindstar Globalgene Technology, Inc. upcoming earnings date is Sep 2, 2025, TBA (Confirmed).

Kindstar Globalgene Technology, Inc. as a current ratio of 2.63, with Debt / Equity ratio of 14.31%

In the past 12 months, Kindstar Globalgene Technology, Inc. has paid 4.49M in taxes.

Kindstar Globalgene Technology, Inc. EV to EBITDA ratio is -9.24, with an EV/FCF ratio of 0.00.

Kindstar Globalgene Technology, Inc. has HK$1.66B in cash and marketable securities with ¥398.36M in debt, giving a net cash position of -HK$1.26B billion.

Gross margin is 47.39%, with operating margin of -5.25%, and net profit margin of -5.89%.

The average price target for Kindstar Globalgene Technology, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―